Advertisement
Screener

Cardio Diagnostics Holdings, Inc. (CDIO) Payments to Acquire Finance Receivables

2.8 / 5 stars · 68/120 Roast Me

Cardio Diagnostics Holdings, Inc. Payments to Acquire Finance Receivables

Cardio Diagnostics Holdings, Inc. (CDIO) reported Payments to Acquire Finance Receivables of $283.01 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireFinanceReceivables · last filed 2023-05-15

  • Cardio Diagnostics Holdings, Inc. payments to acquire finance receivables for the quarter ending 2023-03-31 was $283.01K.
  • Cardio Diagnostics Holdings, Inc. payments to acquire finance receivables for fiscal 2022 was $188.67K.
  • Cardio Diagnostics Holdings, Inc. payments to acquire finance receivables for fiscal 2021 was $0.00.
Period endPayments to Acquire Finance Receivables 3 monthPayments to Acquire Finance Receivables 12 month
2023-03-31$283.01K
10-Q · filed 2023-05-15
2022-12-31$188.67K
10-K · filed 2023-03-31
2021-12-31$0.00
10-K · filed 2023-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
VOLITIONRX LTD (VNRX)$0.003B-0.64
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
BIOMERICA INC (BMRA)United States$0.011B
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92